Compass Therapeutics logo

Compass Therapeutics Share Price Today

(NASDAQ: CMPX)

Compass Therapeutics share price is $2.77 & ₹241.17 as on 6 Mar 2025, 2.30 'hrs' IST

$2.77

-0.01

(-0.36%)

Market is closed - opens 8 PM, 06 Mar 2025

View live Compass Therapeutics share price in Dollar and Rupees. Guide to invest in Compass Therapeutics stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Compass Therapeutics, along with analyst recommendations, forecasts, and comprehensive financials.

Compass Therapeutics share price movements

  • Today's Low: $2.71
    Today's High: $2.95

    Day's Volatility :8.22%

  • 52 Weeks Low: $0.77
    52 Weeks High: $4.08

    52 Weeks Volatility :81.25%

Compass Therapeutics (CMPX) Returns

PeriodCompass Therapeutics Inc.Index (Russel 2000)
3 Months
81.05%
0.0%
6 Months
85.91%
0.0%
1 Year
41.33%
0.0%
3 Years
92.36%
-11.6%

Compass Therapeutics (CMPX) Key Statistics

in dollars & INR

Previous Close
$2.78
Open
$2.83
Today's High
$2.9528
Today's Low
$2.71
Market Capitalization
$384.4M
Today's Volume
$698.1K
52 Week High
$4.08
52 Week Low
$0.765
Revenue TTM
$850.0K
EBITDA
$-56.0M
Earnings Per Share (EPS)
$-0.37
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-36.07%

How to invest in Compass Therapeutics Stock (CMPX) from India?

It is very easy for Indian residents to invest directly in Compass Therapeutics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Compass Therapeutics stock in both Indian Rupees (INR) and US Dollars (USD). Search for Compass Therapeutics or CMPX on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Compass Therapeutics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Compass Therapeutics shares which would translate to 0.314 fractional shares of Compass Therapeutics as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Compass Therapeutics, in just a few clicks!

Returns in Compass Therapeutics (CMPX) for Indian investors in Rupees

The Compass Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Compass Therapeutics investment value today

Current value as on today

₹1,46,391

Returns

₹46,391

(+46.39%)

Returns from Compass Therapeutics Stock

₹41,327 (+41.33%)

Dollar Returns

₹5,065 (+5.06%)

Indian investors sentiment towards Compass Therapeutics (CMPX)

217%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Compass Therapeutics Stock from India on INDmoney has increased by 217% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Compass Therapeutics

  • Orbimed Advisors, LLC

    16.25%

  • Blackstone Inc

    7.29%

  • MPM Oncology Impact Management LP

    6.23%

  • Enavate Sciences GP, LLC

    5.66%

  • BlackRock Inc

    5.01%

  • Adage Capital Partners Gp LLC

    4.36%

Analyst Recommendation on Compass Therapeutics

Buy

    84%Buy

    15%Hold

    0%Sell

Based on 13 Wall street analysts offering stock ratings for Compass Therapeutics(by analysts ranked 0 to 5 stars)

Based on 13 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
11
11
11
Hold
2
2
2
Sell
0
0
0

Analyst Forecast on Compass Therapeutics Stock (CMPX)

What analysts predicted

Upside of 311.55%

Target:

$11.40

Current:

$2.77

Insights on Compass Therapeutics Stock (Ticker Symbol: CMPX)

  • Price Movement

    In the last 3 months, CMPX stock has moved up by 66.9%
  • CMPX vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 66.5% return, outperforming this stock by 25.2%
  • Price to Sales

    ForCMPX every $1 of sales, investors are willing to pay $461.7, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $14.2 for every $1 of sales.

Compass Therapeutics Technicals Summary

Sell

Neutral

Buy

Compass Therapeutics is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Compass Therapeutics (CMPX) Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Compass Therapeutics Inc. logo
-11.22%
85.91%
41.33%
92.36%
-30.4%
Regeneron Pharmaceuticals, Inc. logo
-1.42%
-40.28%
-29.31%
11.08%
44.83%
Beone Medicines Ltd logo
17.63%
36.87%
64.37%
45.89%
71.3%
Vertex Pharmaceuticals Incorporated logo
1.94%
4.92%
19.37%
108.73%
123.83%
Alnylam Pharmaceuticals, Inc. logo
-8.03%
-0.89%
66.53%
52.9%
126.66%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Compass Therapeutics Inc. logo
NA
NA
NA
-0.44
-0.36
-0.24
NA
0.91
Regeneron Pharmaceuticals, Inc. logo
17.86
17.86
1.01
43.09
0.16
0.07
0.01
273.57
Beone Medicines Ltd logo
NA
NA
NA
1.43
-0.19
-0.06
NA
31.22
Vertex Pharmaceuticals Incorporated logo
32.84
NA
1.34
18.07
-0.03
0.13
NA
63.87
Alnylam Pharmaceuticals, Inc. logo
NA
NA
-0.49
0.57
-15.01
-0.03
NA
0.52
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Compass Therapeutics Inc. logo
Buy
$384.4M
-30.4%
NA
0.0%
Regeneron Pharmaceuticals, Inc. logo
Buy
$73.8B
44.83%
17.86
31.07%
Beone Medicines Ltd logo
NA
$29.1B
71.3%
NA
-16.92%
Vertex Pharmaceuticals Incorporated logo
Buy
$124.9B
123.83%
32.84
-4.86%
Alnylam Pharmaceuticals, Inc. logo
Buy
$31.4B
126.66%
NA
-12.37%

About Compass Therapeutics

Compass Therapeutics, Inc., a clinical-stage oncology-focused biopharmaceutical company, engages in developing antibody-based therapeutics to treat various human diseases in the United States. The company's lead product candidates include CTX-009, a bispecific antibody that blocks Delta-like ligand 4 a ligand of Notch-1, and vascular endothelial growth factor A signaling pathways, which are critical to angiogenesis and tumor vascularization; and CTX-471, an IgG4 monoclonal antibody that is an agonist of CD137, a key co-stimulatory receptor on immune cells. It also develops CTX-8371, a bispecific inhibitor that targets PD-1 and PD-L1 checkpoint inhibitor antibodies. The company was founded in 2014 and is headquartered in Boston, Massachusetts.
Organization
Compass Therapeutics
Employees
35
CEO
Dr. Thomas J. Schuetz M.D., Ph.D.
Industry
Health Technology

Management People of Compass Therapeutics

NameTitle
Dr. Thomas J. Schuetz M.D., Ph.D.
Chief Executive Officer
Ms. Vered Bisker-Leib MBA, Ph.D.
Advisor
Mr. Barry Shin J.D.
Chief Financial Officer
Mr. Jonathan Anderman J.D.
Senior Vice President, General Counsel & Corporate Secretary
Anna Gifford
Communications Manager
Dr. Minori Rosales M.D., Ph.D.
Senior VP & Head of Clinical Development
Ms. Karin Herrera B.A.
VP & Head of Clinical Operations
Dr. James Kranz Ph.D.
VP and Head of Chemistry Manufacturing & Controls

Important FAQs about investing in CMPX Stock from India :

What is Compass Therapeutics share price today?

Compass Therapeutics share price today stands at $2.77, Open: $2.83 ; Previous Close: $2.78 ; High: $2.95 ; Low: $2.71 ; 52 Week High: $4.08 ; 52 Week Low: $0.77.

The stock opens at $2.83, after a previous close of $2.78. The stock reached a daily high of $2.95 and a low of $2.71, with a 52-week high of $4.08 and a 52-week low of $0.77.

Can Indians buy Compass Therapeutics shares?

Yes, Indians can invest in the Compass Therapeutics (CMPX) from India.

With INDmoney, you can buy Compass Therapeutics at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Compass Therapeutics at zero transaction cost.

How can I buy Compass Therapeutics shares from India?

It is very easy to buy Compass Therapeutics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Compass Therapeutics (CMPX) be purchased?

Yes, you can buy fractional shares of Compass Therapeutics with INDmoney app.

What are the documents required to start investing in Compass Therapeutics stocks?

To start investing in Compass Therapeutics, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Compass Therapeutics Stock (CMPX)?

Today’s highest price of Compass Therapeutics (CMPX) is $2.95.

Today’s lowest price of Compass Therapeutics (CMPX) is $2.71.

What is today's market capitalisation of Compass Therapeutics?

Today's market capitalisation of Compass Therapeutics CMPX is 384.4M

What is the 52 Week High and Low Range of Compass Therapeutics Stock (CMPX)?

  • 52 Week High

    $4.08

  • 52 Week Low

    $0.77

What are the historical returns of Compass Therapeutics (CMPX)?

  • 1 Month Returns

    -11.22%

  • 3 Months Returns

    85.91%

  • 1 Year Returns

    41.33%

  • 5 Years Returns

    -30.4%

Who is the Chief Executive Officer (CEO) of Compass Therapeutics ?

Dr. Thomas J. Schuetz M.D., Ph.D. is the current Chief Executive Officer (CEO) of Compass Therapeutics.